Sensorium Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Sensorium Therapeutics, Inc.
Quantité totale PI 36
Rang # Quantité totale PI 40 572
Note d'activité PI 2,7/5.0    53
Rang # Activité PI 13 532
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

14 1
2 0
19 0
0
 
Dernier brevet 2025 - Therapeutic alkaloid compounds
Premier brevet 2022 - Solid forms of mesembrine and th...
Dernière marque 2025 - SENSORIUM
Première marque 2025 - SENSORIUM

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Therapeutic alkaloid compounds. Disclosed are compounds that are derivatives of mesembrine or me...
P/S Pharmaceutical preparations for human use for the treatment of diseases of the central nervous sy...
Invention Delivery of therapeutic alkaloid compounds. Disclosed are prodrug compounds that can be converte...
2024 Invention Therapeutic alkaloid compounds. Disclosed are compounds useful for inhibiting SERT, and related m...
Invention Therapeutic alkaloid compounds. Disclosed are compounds that are derivatives of mesembranol or m...
Invention Inhibiting serotonin transporter protein (5-htt). Disclosed are compositions comprising mesembra...
Invention Delivery of therapeutic alkaloid compounds. Disclosed are compounds that can be converted to mes...
Invention Alkyl-substituted derivatives of mesembrine and mesembrenone and therapeutic uses thereof. Discl...
Invention Delivery of therapeutic alkaloid compounds. Certain pharmaceutical compounds are disclosed herein...
Invention Therapeutic alkaloid compounds. Disclosed are compounds that are derivatives of mesembrine, and r...
Invention Therapeutic alkaloid compounds. Disclosed are compounds that are derivatives of mesembranol or me...
Invention Solid forms of mesembranol and therapeutic uses thereof. Solid forms of mesembranol are provided,...
Invention Delivery of therapeutic alkaloid compounds. Disclosed are prodrug compounds that can be converted...
2023 Invention Delivery of therapeutic alkaloid compounds. Disclosed are compounds that can be converted to mese...
Invention Inhibiting serotonin transporter protein (5-htt). Disclosed are compositions comprising mesembran...
Invention Alkyl-substituted derivatives of mesembrine and mesembrenone and therapeutic uses thereof. Disclo...
Invention Solid forms of mesembrine and therapeutic uses thereof. Solid forms of mesembrine are provided, a...
Invention Therapeutic alkaloid compounds. Disclosed are compounds that are derivatives of mesembrine or mes...
2022 Invention Solid forms of mesembrine and therapeutic uses thereof. Solid forms of mesembrine are provided, ...
Invention Deuterated forms of alkaloid compounds and therapeutic uses thereof. Disclosed are deuterated for...